Rice Hall James & Associates LLC raised its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 24.3% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 83,338 shares of the medical instruments supplier's stock after purchasing an additional 16,297 shares during the quarter. Rice Hall James & Associates LLC owned 2.39% of Utah Medical Products worth $5,576,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Copeland Capital Management LLC acquired a new stake in shares of Utah Medical Products in the 3rd quarter valued at about $53,000. Allspring Global Investments Holdings LLC acquired a new stake in Utah Medical Products during the second quarter valued at approximately $83,000. Victory Capital Management Inc. lifted its holdings in Utah Medical Products by 124.4% during the 2nd quarter. Victory Capital Management Inc. now owns 2,673 shares of the medical instruments supplier's stock worth $179,000 after buying an additional 1,482 shares during the last quarter. EntryPoint Capital LLC grew its position in shares of Utah Medical Products by 124.1% in the 1st quarter. EntryPoint Capital LLC now owns 3,240 shares of the medical instruments supplier's stock worth $230,000 after acquiring an additional 1,794 shares in the last quarter. Finally, Exchange Traded Concepts LLC acquired a new position in shares of Utah Medical Products in the 3rd quarter worth approximately $304,000. 69.60% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Separately, StockNews.com upgraded Utah Medical Products from a "buy" rating to a "strong-buy" rating in a research note on Wednesday.
Read Our Latest Stock Analysis on UTMD
Utah Medical Products Price Performance
Shares of NASDAQ UTMD traded up $0.71 during mid-day trading on Friday, hitting $64.09. The company had a trading volume of 18,079 shares, compared to its average volume of 21,778. Utah Medical Products, Inc. has a 12 month low of $63.38 and a 12 month high of $87.86. The stock has a market cap of $223.03 million, a price-to-earnings ratio of 14.84 and a beta of 0.08. The firm's 50 day simple moving average is $66.26 and its two-hundred day simple moving average is $67.40.
Utah Medical Products Profile
(
Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Read More
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.